Showing 221 - 240 results of 112,734 for search '(( 12 we decrease ) OR ( 5 ((mean decrease) OR (((teer decrease) OR (a decrease)))) ))', query time: 1.70s Refine Results
  1. 221
  2. 222

    FABP5 overexpression decreases inflammation and increases innate immunity in primary NHBE cells. by Fabienne Gally (260470)

    Published 2013
    “…<p><b>A.</b> CS exposure decreases <i>P. aeruginosa</i> colony forming units (CFU) on primary NHBE cells overexpressing FABP5. …”
  3. 223
  4. 224
  5. 225
  6. 226

    MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

    Published 2025
    “…<p><b>A.</b> Experimental schedule. All mice underwent behavioral tests following CRS treatment. …”
  7. 227
  8. 228
  9. 229
  10. 230

    TRIM5 restriction of HIV-1 has decreased during evolution leading to humans. by Michael Emerman (12304)

    Published 2013
    “…<p>The shading of the rectangle represents the degree that TRIM5 will limit infection of HIV-1 (darker color means TRIM5 decreases HIV-1 infection more) and the X-axis indicates time in millions of years from the present. …”
  11. 231
  12. 232

    Tau phosphorylation is decreased in neurons treated with 20 mM KCl. by Nguyen-Vi Mohamed (323606)

    Published 2017
    “…The phosphorylation of S199/S202, T181, T205 and S404 was not significantly affected by 10mM of KCl treatment whereas the phosphorylation of all these sites was decreased by 20mM of KCl treatment. The signal of the phospho-antibodies was normalized to that of total Tau (n = 5, mean ± SEM, unpaired t-test two-tailed, *<i>P</i> < 0.05, ***<i>P</i> < 0.001). …”
  13. 233
  14. 234
  15. 235
  16. 236

    Structure of YOLOv5s-SBC. by Zhongjian Xie (4633099)

    Published 2024
    “…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”
  17. 237
  18. 238

    S1 Data - by Toru Hosokawa (364158)

    Published 2023
    Subjects:
  19. 239

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  20. 240